August 28, 2025 • 49 mins
In this episode of the Gladden Longevity Podcast, Dr. Jeffrey Gladden and Steve Reiter explore various aspects of longevity, including organ age testing, the pace of aging, multi-drug gerotherapy, the role of GLP-1s, gene therapy, and the importance of lifestyle choices in optimizing health and longevity. They discuss innovative testing methods to assess organ health, the implications of aging rates, and the potential of new therapies to enhance longevity. The conversation emphasizes the significance of understanding individual health metrics and making informed lifestyle choices to achieve optimal health outcomes.
For Audience
· Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/ !
Takeaways
· Every organ has its own age, impacting overall health.
· Understanding organ age can help tailor longevity strategies.
· New tests can predict health risks before they manifest.
· Multi-drug gerotherapy offers a new approach to aging.
· GLP-1s have benefits beyond weight loss, including heart health.
· Gene therapy may offer new avenues for reversing aging.
· Lifestyle factors remain crucial for longevity and health.
· Regular sauna use significantly reduces all-cause mortality.
· Testing and monitoring are essential for personalized health.
· Combining therapies can enhance the effectiveness of treatments.
Chapters
00:00 Introduction to Age Hacking and Organ Age Testing
01:26 Understanding Organ Age and Proteomic Testing
07:58 The Pace of Aging and Longevity Insights
12:54 Senolytics and Multi-Drug Gerotherapy
23:53 Cleaning the System for Regenerative Therapies
25:46 Rejuvenation Factors and Supplements
26:02 Exploring GLP-1s Beyond Weight Loss
34:39 Gene Therapy and Epigen
Mark as Played
Transcript
Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
(00:28):
Welcome to the Gladden Longevity Podcast with Dr.
Jeffrey Gladden, where our passion is helping you become an age hacker.
On this show, we want to help you optimize your life energy, longevity, health, and humanperformance with impactful and actionable information by answering five questions.
How good can we be?
How do we make 100 the new 30?
(00:48):
How do we live well beyond 120?
How do we live young for a lifetime?
And how do we develop a 300 year old mind?
I'm Steve Reiter and
Dr.
Gladden, we're back for another monthly Q &A.
Yeah.
Excited to do it with you.
Good to see you, Steve.
Yeah.
see you too, my man.
(01:08):
So how's your August gone thus far?
it's been pretty amazing actually, lots of cool things.
And, we're actually in this podcast, we're going to talk about some of the stuff that I'vegot coming up.
So, even next week, so it'll, it's going to be a good August all the way through.
next week.
Well, the first topic we're going to talk about is proteomic organ age blood tests and thepace of aging markers.
(01:36):
I've never heard of an organ age test.
This is new to me.
right.
we're theoretically answering listeners questions, but I will tell the audience that Itook poetic license here and wanted to share with you things that I think you'll find
interesting to hear about.
And the first one is to understand that, of course, we're a mosaic of many ages.
(01:58):
You've heard us talk about that on the podcast before, and every organ really has its ownage, if you will.
Um, mm-hmm.
mean, I think about that when I think of someone who's drank their entire life.
Obviously their liver is going to be older, if you will, than the rest of their body.
And I'm sure other organs, but I didn't really realize that my kidneys could be older thanmy liver or my heart.
(02:25):
Absolutely.
Yeah.
No, every organ system is kind of a standalone, you know, down to bone, skin, muscle, andthen the internal organs, you know, all the internal organs, pancreas, liver, kidneys,
adrenal glands, stomach, GI tract, colon, heart, lung, and then brain, of course, and thenervous system in general, which is another really, really interesting area.
(02:50):
You know, one of the things that we've been doing is as we've been doing functionaltesting to look at those organ systems, like what is your VO2 max?
You know, what are your liver parameters based on blood testing?
What are your kidney parameters based on blood testing?
And we go about that with more comprehensive panels than most people certainly in generalmedicine would do.
And yet beyond that is another layer of
(03:12):
kind of peeling back the onion on what is the age of your organs.
And so with DNA methylation testing, TrueAge Diagnostics is the company that we've beenusing.
They will give you organ system ages for about 11 or 12 different organs, your brain, yourheart, your kidneys, your liver, your lungs, things like that.
And what they're doing is they're looking at DNA methylation patterns
(03:36):
that are reflective of those organs and then essentially estimating the age of that organ.
And then they give you a composite age of all of those organs, right?
So you get the composite age and then you get the breakdown per organ system, which isinteresting.
If you peel the onion back a little bit further, you can actually look at protein markersin the blood, which is referred to as proteomics.
(03:59):
em And
So now you've moved outside the nucleus of the cell where the DNA methylation patterns arebeing identified and now you're looking into the cytoplasm of the cells and in the blood
it's the plasma itself and you're looking for proteins and those proteins, theconfiguration of those proteins, the number of proteins that there are of particular types
(04:23):
will create a picture.
of what the underlying organ status is or age is in this case, right?
So, and what's happening is they're looking at these uh protein profiles compared to theselarge cohorts of people where they've collected this in the past.
(04:46):
for example, in the UK, there's a biobank that has about 45,000 individuals in there.
And so they can compare
your protein signature profile to 45,000 other people to give you an idea of kind of whereyou stand in the against the general population.
Right.
And it turns out that it can be helpful for identifying problems prior to them sort ofshowing up.
(05:12):
And there's there's a new test that we're excited to get our hands on.
It's not here yet.
I talked with the CEO of the company.
last week, actually, via email.
And he tells me that the lab, they're a company out of India called TZAR.
He tells me that the lab in the US is going to open up in Denver.
(05:34):
He said they were getting ready to sign some agreements and then they need to kind ofbuild it out.
So hopefully this fall.
Of course, I've been told it'll be in three months, about six times.
But that being said,
When that comes online, they have a test called an all-organ biopsy that's now looking ata combination of proteomics and transcriptomics, which are the messenger RNA signals that
(05:59):
come off of the DNA.
And combining those two things with some DNA profiling, et cetera, to give you what theycall an all-organ biopsy where you can go in and through that technology also get a status
update on each organ system.
And if you're really serious about longevity, then it's important to understand thatyou're really only as young as your oldest age, right?
(06:26):
So you really want to know what is the status of each organ.
It's kind of like, um, you know, building a company, you want to know the status of eachdepartment, how well is it performing?
Or if you've got a race car, for example, you want to know what each of the componentsstatus is because your car is only going to be as good.
durable and fast as the weakest component.
(06:48):
So same is true for us.
And so it's really exciting to me to see that testing is really rapidly moving in thisdirection.
Now, the omics testing right now, the proteomics I was talking about, there is a group outof Stanford apparently called Vero, V-E-R-O slash T-E-A-L, Vero Steel Omics that
(07:11):
has research partnerships.
And those tests are gonna be around $1,000 probably to get things done to look at your oldorgan age.
The all organ biopsy test is gonna be five or $6,000 to get that done from what Iunderstand.
So these tests are not necessarily inexpensive, but they are remarkably proficient atcharacterizing
(07:34):
not only a status, but in the case of T-SAR, actually telling you things you might beheaded towards, like are you headed towards dementia?
Are you headed towards a heart attack?
Are you headed towards a stroke?
Are you headed towards developing cancer for that matter?
And so getting that sort preemptive information becomes really very powerful.
So this is one of the reasons we're so interested in it.
(07:56):
And then of course there is...
Many people have heard about the pace of aging.
This was popularized by Brian Johnson with the Longevity Olympics, where he was using oneparticular parameter, the rate of aging, if you will, that came out of a town in New
Zealand called Dunedin, D-U-N-E-D-I-N, Dunedin.
(08:17):
And it was called the Dunedin Pace Trial.
They ran a trial over there in New Zealand to see how people were aging.
And from that, they...
looked at DNA methylation patterns and developed this clock, if you will.
So you can see in a chronological year how much you're aging.
Are you aging more than one year when you go through a chronological year or are you agingless than one year?
(08:38):
And so this is also nice to superimpose on top of these ohmic ages, if you will.
So the bottom line is that we're getting better at
and actually understanding where somebody is in the aging process, which of course is thefirst thing you've got to know if you're going to make the race car race longer or faster
(08:58):
or better, right?
And then there's a lot of things that can be done if you find that there are manylifestyle interventions or many supplements and things that you can modify depending on
the findings, but it's a really, really cool area.
Hmm.
know how that strikes you as every man on the call here, Steve, but it's prettyintriguing.
(09:23):
We're doing a lot of the testing.
I mean, we're all the testing now.
And in fact, some years ago, I developed a proteomic and transcriptomic test to look atthis very thing related to the hallmarks of aging.
It's just that at that point in time, it was prohibitively expensive to do it.
became almost like $14,000 or $15,000 to do a test.
And it was just like...
(09:43):
You know, nobody can really justify that.
So it's nice to see that things are progressing and getting cheaper.
Yeah.
So how much is that looking to be in terms of being tested now that things are gettingcheaper?
Yeah.
So it's going to be, know, you right now, if you want to do a true diagnostic test and youwant to do a combination of several of their tests, it's I don't have the exact numbers in
(10:12):
front of me, but you can probably get that done for, I'm going to say an interpreted andgone through and everything for around a thousand dollars.
Right.
So it's not.
Yeah, not.
drop from the 1415 that you had developed.
well, it's a little bit different.
It's a little bit of a tangential test to what I was developing.
The other tests that are being developed, though, seem to be sort of shaving some expenseoff of that.
(10:37):
But I was doing uh both proteomics and transcriptomics, which is looking at RNA andproteins both, right.
And the tests that we've been talking about are just proteomics only, right.
So they are going to be cheaper.
just by default, but even with that, they're getting cheaper.
Even the proteomics are getting cheaper, right?
So now we're down around maybe $1,000, $1,500, something like that.
(10:58):
yeah, mm-hmm.
Yeah, so it's good stuff.
So.
excites you about this and practically how do you see this helping people in their healthjourney?
Yep.
So practically there are two sides of the coin.
One is, I headed towards a cliff?
I don't know I'm headed towards.
This is a, this is, this is way to identify that and which organ system is involved inthat.
(11:22):
Is it your immune system?
Is it your cardiovascular system?
Is it your brain?
All those things can be answered.
And as a testing is refined, particularly with the T-SAR testing, we'll be able to see, it
Alzheimer's, is it Parkinson's?
Is it a stroke versus a heart attack?
You know, these kinds of things.
So there's even more precision in knowing what cliff you might be headed towards.
(11:45):
The second reason it's really important is if you're not headed towards a cliff, you maybe looking towards a cliff, right?
You're not running towards it, but you're kind of pointed in that direction.
That's helpful because if you can intervene sooner, you can steer yourself away from that.
even looking in that direction, let's say, right?
And if certainly if you're running towards it, there's a lot that can be done to slow thatdown or go the other way to where you're running away from it, right?
(12:09):
So that's the power of knowing.
There are lots of interventions we can do to do that.
Then the other thing is that for the people that are really looking to optimize theirlongevity through their lifestyle and supplements and sleep and the trackers, the
wearables and things and all the things that they're doing, the question,
becomes, well, jeez, I'm doing all this.
How well is it working out?
(12:30):
Right?
How good am I doing?
And am I putting the energy, time, attention, and resources into the things that matterthe most?
And so this gives you an idea to see what matters most and adjust your interventions tomake sure you're addressing the things that are most important as you keep the other
things going forward.
(12:51):
it's positive all the way around as I see it.
Yeah, yeah, sounds incredible.
So the next topic you wanted to talk about was senolytics and multi-drug gerotherapy.
Rapamycin and Tramatinib?
(13:12):
Well, it's the Satinib and Kursatin is one.
Those are two medications that people have heard about.
But let's talk about, and Fisetin is on there as a nice analytic, about 20 milligrams perkilogram per day.
So you can get your weight, take your weight divided by 2.2, that's your weight inkilograms and multiply by 20 milligrams.
(13:32):
And now you've got a dose of how much Fisetin you might want to take two days in a row.
and that you don't have to be taking it every day.
And you might want to repeat that every couple of months.
But what's helpful in pruning senescent cells is, again, with new testing that we have,there's a new test called Sapir P16 that looks at senescence in the immune system.
(13:57):
There's a UCLA test that looks at the anatomy of the immune system to give you an idea ofsenescence.
also from the true age DNA methylation, they will give you a snapshot of your immunesystem and how youthful or senescent it may be.
So we have ways, and then there's another test that can be done that looks atbeta-galactosidase, which is not the most perfect marker for senescence, but it does give
(14:20):
you kind of a ballpark feeling of what's going on.
And so that's interesting also.
So if you have an idea that your senescent cell burden is building up, as it does as weage, and of course these are the zombie cells that simply take up space and don't really
function, so it's like having a company with 100 employees and 20 of them show up to worksenescent, it means they're taking up space, but they don't do anything.
(14:42):
So the productivity of the company goes down, but then when they become secretory, nowthey're secreting these inflammatory cytokines into the environment, and now they start
recruiting other employees
to become senescent, so they stop working.
And then they're turning off the lights and the wifi and locking the doors and making itdifficult for the people or the cells or the individuals in this analogy who still are not
(15:07):
senescent, it makes it very difficult for them to work properly.
And so this is a big part of why aging is an exponential process, right?
Because it's a downward spiral and you can see that if you had a company and now you have20 and then you have 30,
and then 35 and then 38 and then 40 employees that are in this scenario and the lights areoff, you can see the company is just going to crater, right?
(15:30):
mean, the productivity is going to crater literally.
So that's what aging is.
And so being able to actually prune these senescent cells, fire these people from thecompany, right?
So that they leave is very important.
And in doing so, you're starting to turn down the inflammation.
that goes along with aging and the inflammation is driving more oxidative stress at thecellular level, which is also very damaging to the underlying, you know, functioning parts
(16:00):
of the, of the cell and other cells that are working properly.
So it's a real kind of a cleaning house kind of scenario.
Now, what we found is that, we really liked the P16 INK4A test that I mentioned was a
SAPIER bio, S-A-P-E-R-E, it's great and it can actually be treated by taking SGLT2s.
(16:23):
It's been shown to actually reverse that.
These are diabetes medicines that basically stop glucose from being reabsorbed through thetubules in the kidneys and you excrete the glucose into the urine.
which can lower blood sugar.
It's also been found, so it's used for diabetics, but then it was found that it's actuallygood for heart disease.
It's good for arterial disease.
(16:44):
And now it's being shown to actually be good at rebooting the immune system fromsenescence back to an active immune system, right?
Which is super important.
And the reason having an active immune system that's not senescent is so important.
is because it's your immune system that's out there.
The natural killer cells are actually pruning senescent cells for you.
(17:06):
So as you make the immune system more youthful, you now start to actually do for yourselfwhat previously you were asking the supplements to do.
And you're also scavenging for tumor cells when they show up and you're killing thosebefore they actually take hold and develop actual cancer, right?
So.
When you think about people that make it past 100, they really have three things incommon.
(17:30):
They have really robust immune systems.
They have very good cardiovascular systems, and they actually have very resilient brains,right?
And those seem to be, I mean, there are other things, of course, as well, but those threeseem to really be central.
So.
is kind of the drivers of having robust immune system, cardiovascular, healthy brain asyou age?
(17:59):
Is it genetic?
Is it lifestyle?
Is it a combination of those two?
Is it something else?
Well, there's always your genetic component to everything, but lifestyle plays a role.
You know, the more inflamed you are, the more infections that you face, the more timesyour immune cells have to divide.
And every time they divide, those telomeres inside the immune cells get shorter.
(18:23):
So the immune system is very susceptible to telomere shortening.
And I hadn't mentioned telomere shortening yet.
but I was about to when you asked the question, so I'll mention it now.
When telomeres get short, being able to re-lengthen telomeres, right, through things likeTA65 or Isogenics or TAM818 or now hyperbaric oxygen therapy if you want to wear a mask
(18:44):
for 90 minutes a day, five days a week has been shown.
Brian Johnson showed he reversed telomere lengths for himself.
There are other therapies out there now looking at gene therapies where they insert
the TERT gene into the cell using an adenovirus vector and they put it into the cell, notinto the nucleus, but into the cytoplasm of the cell so that now you're making more
(19:07):
telomerase, which is the enzyme that re-lengthens telomeres.
And that's interesting also.
So the point is that there are things to re-lengthen telomeres, but equally important isremoving things that are shortening telomeres.
You can't re-lengthen what you're actively shortening, right?
Um, so the first thing to do is to stop shortening the telomeres.
(19:28):
Well, how do you do that?
Well, one is you, you know, if you've got chronic allergies, if you've got chronicinfections, if you've got mold, if you've got Lyme, if you've got, you know, gut issues
that are, keep you chronically inflamed, your immune system is dialed up all the time.
It's working over time and those telomeres are shortening and it's getting weaker and ismuch more prone to become senescent earlier.
(19:50):
I don't know if that helps answer your question, but.
That's a big piece of it, the lifestyle piece and the chronic infections, things you'reexposed to, right?
So, yeah.
So the interesting thing about the senescent cells is when they occur and they start tosecrete these inflammatory cytokines, we can measure those.
(20:11):
We can measure IL-6 and TNF alpha, right?
And HSCRP, all of those are indicators.
And then there are other ways to help with this system.
So what we do is we will use a senolytic
system like say, Fisetin and we'll take it and then we'll do, in fact, I'm going to do aplasma foresis on Monday.
(20:35):
I'll probably take some Fisetin over the weekend for two days.
Prior to...
prior to this plasmapheresis because I'm gonna be basically killing off senescent cells.
I just got a test back from TrueAge in June and I don't have a lot of senescent cells andI did the Saphir P16 test and I have a very youthful immune system, like incredibly
(20:56):
youthful, right?
Like a lot of naivete in my immune system, not a lot of overcommitted cells.
my immune system is youthful in sense that it can adapt to new challenges, right?
So I'm gonna, through the testing, through the testing, yeah, you do the tests.
So anyway, I'm gonna take some Fisetin over the weekend and do Plasmapheresis.
(21:17):
Well, why would you do that?
Well, it's great because if you're gonna go in and kill these senescent cells, you'regonna basically dump a bunch of gunk into the system, right?
You do Plasmapheresis, you take all of that out.
Plasmapheresis is when you,
hook yourself up to the machine and you're pulling blood out of one arm.
You run it through a large centrifuge, which separates the cells, right?
(21:37):
The red cells and the white cells and the platelets, they sink to the bottom as thecentrifuge spins.
And then the plasma rises to the top.
Well, in the plasmas where all those inflammatory cytokines and proteins are.
So you throw that away and we can throw away three liters at a time, right?
And replace it with saline and albumin.
We can do that safely.
And so when you do that, it's almost like now you've killed off the bad guys and nowyou've cleaned out the system.
(22:03):
And then we all.
It is quite a bit.
It's almost like a full oil change, right?
Um, if you're going to donate plasma, you can only donate 200 CCs at a time, but you candonate two times a week, right?
So you replenish your plasma quickly.
but this seems.
Yeah.
is significantly more than.
(22:26):
That's right.
That's my point.
I'm putting it in perspective.
It's a lot more than 200 ml.
So it'd be five of those in a liter, right?
So this would be 15 times that.
Yeah, but it has the ability to actually really clean the system, right?
If you're going to clean the system, you clean the system and then the body rejuvenatesvery quickly, right?
And so anyway, this is a really, really powerful
(22:51):
scenario and when we're working with people that are, let's say they've sold a company andthey leverage their health to kind of get it across the finish line, right?
And they know it, they've been burning midnight oil and they're stressed and they haven'tbeen eating well, haven't been able to exercise and all that stuff.
Their body is full of these senescent cells.
And we can go in and through a series of these, right?
(23:12):
Like maybe doing this every month or six weeks.
for three, four, five, six sessions, you can actually really start to reboot somebody.
Whereas it would take them years to try to reboot what we can do in a matter of months uhusing something like this.
And then of course there's other interventions with lifestyle changes and teaching them tomanage stress and other things.
(23:33):
anyway, it's a great hack to be able to kind of go in and salvage somebody as well as forpeople that are doing well to intermittently.
you know, maybe every quarter or every four months or something like that, three times ayear doing this to kind of keep them to keep them young.
Right.
So, yeah.
(23:53):
So the idea then is to clear out the bad stuff and then rebuild.
That's it.
That's it.
You don't want to try to rebuild in the middle of a mess.
And this is also true if you're going to be doing regenerative therapies with stem cellsor exosomes or embryonic, you know, placental or cord blood factors or, whatever you have
(24:21):
access to PRP for that matter, platelet rich plasma, which is full of different signalingmolecules.
So
There are many regenerative tools out there, but those regenerative tools, my analogy forthat is that those are like Olympic swimmers, right?
And if you put those Olympic swimmers into a swimming pool that's full of, you know, lawnchairs and, and, and logs and sticks, branches from trees that are fallen in there,
(24:49):
they're not going to be able to do a very good job.
In fact, if you take stem cells and you put them into a Petri dish with
uh somebody, an older person's plasma, they die.
They don't do anything.
They die.
Okay.
And if you put them into the plasma of a young person, then they start to actually dotheir work.
(25:11):
Which isn't that interesting?
Yeah.
So you really want to, if you're listening to this, it's so important if you've got aproblem and you're thinking about
Oh, I want to fix my knee, my hip, or, you know, I'm thinking about getting a stem cellprocedure, even for your skin, for your face or whatever else.
you know, my doctor wants you to do exosomes.
(25:32):
Okay, that's great.
But if you haven't cleaned out the swimming pool, right, you're not going to get nearlythe results that you would if you sort of sequence it properly, where you actually prune
the senescent cells, take out the trash.
and then start to put in the rejuvenation factors and then support those rejuvenationfactors with other factors, right?
(25:53):
To write supplements for the indication, the right peptides for the indication, that kindof thing.
So, yeah.
Well, the next topic that you wanted to talk about big in the news right now, GLP ones,but this is GLP ones as Jero therapeutics beyond weight loss.
(26:14):
know about GLP ones for weight loss, but this was kind of interesting as something elseyou could use it for.
Yeah, so GLP-1s in my mind have really turned into a mixed bag.
They have really turned into a mixed bag.
So when GLP-1s are introduced, they were introduced basically to aid with diabetescontrol, right?
(26:38):
So a GLP-1 agonist would go in and when you take in sugar, and creatine comes in, GLP-1comes in, GLP-1 causes glucagon to go to work, but it also...
boost insulin release, right?
So that all of a sudden now you're managing the sugar that came in better than you wouldhave otherwise.
And so that was the theory behind them.
(26:58):
But then they discovered that the GLP-1s were actually having a beneficial effect on heartdisease, that people were less prone to heart attacks, that their arteries were doing
better, right?
And that their kidney function was improving.
because diabetics, you know, always have kidney compromised and they start to find thatthe protein that was leaking in the urine was going down and that the trajectory of kidney
(27:24):
loss was changed.
They were losing kidney function at a slower rate or they were maintaining kidney functionand not losing it at all.
And in some cases actually reversing kidney functioning, having kidney function improve.
And so...
Right.
So all of a sudden it's like, wow, these, these GLP ones are having a lot of let's call itoff target effects that are very useful.
(27:49):
And then it started to be shown that, you know, they, they could decrease appetite.
So then they were scooped up, as weight loss drugs.
Right.
And there are a number of them out there, ozempic,
And it's probably, you know, kind of the hallmark, GLP-1.
And then there are other combinations of GLP-1s and GIPs, are little different peptides.
(28:13):
These are peptide drugs, by the way.
Again, modulate the same system.
Moderna is one.
And the deal here is that they will decrease appetite and hunger.
and they'll decrease, they'll also slow gastric emptying.
The downside to these drugs when they're used for weight loss or when they're used at allis that you can develop pancreatitis.
(28:35):
You can develop gastric stasis, right?
Where the stomach doesn't empty.
And what we find, people come to us all the time that are taking GLP-1s, or we have peoplethat come in and they want to start a GLP-1.
So we'll start a low dose GLP-1 for them.
very cautiously and what we've seen as we've looked at mixed populations of people is thatpeople are losing weight, but they're losing muscle preferentially.
(29:03):
And the fat that they're not really losing much in the way of fat because when you'restarving, so to speak, not getting enough calories, fat is not enough to sustain you.
Fat is simply calories, but the body needs other things.
It needs minerals and it needs vitamins and things like that that are inside muscle cells.
So when you're fasting, like a three day fast, a five day fast, we had a guy come in herewas on a 14, no, an 18 day fast, water fast.
(29:31):
We measured his, right.
And he just did this on his own without asking us, but he came back and we measured him.
He'd lost a ton of muscle and not very much fat at all.
And bone density goes down for these people.
So we think that GLP-1s, while they are good at sort of modulating appetite, the weightloss is not really constructive weight loss.
(29:54):
It's really our idea of weight.
It has to do with actually body composition.
Like we don't care what people weigh.
What we care about is what their muscle mass is and what their body fat is.
And you can be you can be six foot and 200 pounds and have a, you know, percent body fatof eight and be an amazing shape.
(30:16):
Or you can be 200 with a percent body fat of, you know, 30, right.
And be in terrible shape.
So it's not about the weight.
It's really about what's the composition of the body.
So we see that the GLP-1s when they're used for weight loss, many times are used too longand too high dose and leading to what I would call unhealthy weight loss.
Right.
So it's a big problem.
(30:38):
There are better ways out there to lose weight.
There's a drug, not a drug.
There's a supplement called Mimeo, M-I-M-E-O, Mimeo, M-I-M-E-O, I-I-O, maybe that's it.
I was trying to think there was an I in there.
Yeah, Mimeo.
So M-I-M-I-O, which basically
(30:59):
Um, has several components in it.
It has a bit of niacin.
So if you take too much niacin, it'll give you diarrhea.
So just know that I've done it, uh, and it's happened.
Um, but if you take two or three, uh, you should be okay.
And, different people's GI tracts are more or less susceptible to it, but it also has OEAand PEA and OEA basically decreases appetite and PEA decreases inflammation in the brain.
(31:27):
And
That supplement works remarkably well.
You can actually dial in your appetite suppression based on how many capsules you take.
You take one, you're not gonna feel much.
You take two, you feel a little bit.
You take three, it's, yeah, I'm feeling not really that hungry.
You take four, it's like, I'm not really hungry at all.
So you can actually dial in appetite suppression that way as a way to kind of retrainyourself.
(31:49):
And the other thing that's super helpful is to do a five-day fast-mimicking diet, which isactually a kit that's been designed by Prolon.
And in that kit, you are fasting, quote unquote, for five days, but you're actually eatingat the same time, which sounds paradoxical.
How can I be eating and fasting simultaneously?
Well, what they've done is they've orchestrated these meals, quote unquote meals to besuch that you do a couple of things.
(32:16):
One, you get in nutrients that your body needs, so you're not having to pull from muscleto they're giving you a little bit of carbohydrate so that you don't have to pull from
muscle either.
So they've shown that with a five day fat-swinging diet, you're not actually losing muscleor bone density.
This has been studied.
So that's very interesting.
But what you are doing is you are pulling from fat cells.
(32:38):
You are also changing insulin resistance.
You're also resetting your gut biome.
You're also changing your taste buds.
You're shrinking your stomach.
So you're, decreasing your appetite.
And at the end, it can be a good way to jumpstart into
a body composition optimization program where now you're going to take Mimeo, you're goingto do a fast mimicking diet, initially, maybe once a month for three months or so until
(33:05):
your system gets regulated.
But we feel like that's a much healthier way.
That being said, there is a role for GLP-1s and there's microdosing of GLP-1s, which seemsto give a lot of the benefits in the longevity space, brain health and things like that.
without
all the appetite suppression and all the side effects, right?
So it's about a 10th of the dose of a normal GLP-1.
(33:26):
So to go full circle on the GLP-1s, I think they still have a role, certainly a role fordiabetics.
And I think they still have a role in longevity.
It's just that when they're used for weight loss, I think they're actually beingcounterproductive.
interesting, huh?
So the idea is micro dosing, GLP ones to get that heart, kidney, cardiovascular benefits.
(33:50):
That's right.
And they're also showing now that it helps in osteoarthritis.
There's some new studies related to that, cardiovascular disease, as I mentioned.
So it's pretty interesting.
Yeah.
So that's fascinating because with everything I've heard about women and even some mendeveloping osteoporosis, using it to lose weight, that a microdose can get the benefits of
(34:19):
the good stuff without getting hit with the bad.
That's right.
You know, there's, I forget who said this, but it was said a long time ago.
But, you know, everything is medicine or everything is poison.
It's just a question of the dose, right?
Yeah.
(34:40):
Interesting.
All right, gene therapy and partial epigenetic reprogramming, OSK.
Yeah, so this is pretty fascinating.
So as I mentioned earlier, we were talking about inserting TERT, the gene TERT into thecytoplasm of the cell.
Well, it turns out you can actually insert several different genes.
(35:02):
You can insert Clotho, a Clotho gene to increase Clotho production.
We can actually measure Clotho in clients.
There's a couple different ways to do that.
And then you can also insert uh Tert, you can insert folistatin, which actually keeps youfrom breaking down muscle, right, which is interesting.
And there's some other genes that are being used also to help optimize longevity and bodycomposition, if you will.
(35:30):
So that's one approach to, you know, genetic.
quote unquote reprogramming to optimize youthfulness as we age.
The Japanese scientist, Dr.
Yamanaka discovered that he could reprogram the epigenetic age of a cell by activatingfour different genes.
(35:51):
And if he activated those four genes inside of a cell and he left them activated,
long enough, the cell would return to a pluripotent stem cell.
This is when the Nobel Prize was awarded for this back in 2012-ish, I think it was.
And we all heard about the fact that, my gosh, you can make a stem cell out of a skincell.
Do remember that when that was on the news?
(36:12):
Yeah.
That's an induced pluripotent stem cell.
It's induced by activating the Yamanaka factors to create a pluripotent, which means itcan become anything, stem cell.
So the problem with the Yamanaka factor activation is that
When you're activated, you actually increase your risk of cancer because the cellsde-differentiate enough that they kind of lose track of what they are, right?
(36:35):
And so now not only can they become anything, but they can also become cancerous.
So they figured all this out in mice and then they took away one of the genes that was theprime culprit.
So now they're only using three of these in mice and they're actually pulsing them on andoff.
I won't go into the mechanism, but they actually make them sensitive to a typical to a uhto an antibiotic that will either turn them on or off and doxycycline, I believe.
(37:02):
And with that, they could sort of in the stepwise fashion make a cell more useful, right?
Make a mouse more useful, right?
But they still found if they went too far that the mice would develop cancer.
So that was interesting.
Then a paper published in July of 2023 out of David Sinclair's lab at Harvard, who is oneof the major longevity researchers, was really interesting because they hypothesized that
(37:32):
they could actually reprogram the epigenetics of a cell in the same way that the Yamanakafactors did.
And what they would do is they would use instead of
gene therapy, let's call it, or gene manipulation, they would just use a combination ofmedications and supplements.
(37:53):
So think of it as chemical reprogramming of a cell.
And what they ended up showing was that with a specific combination of valproic acid,which is used for seizure modulation, it's a histone deacetylase inhibitor.
And we haven't gotten into
that, that's another topic, but it has to, it's kind of connected to DNA methylation.
(38:16):
And then a molecule called CHIR99021.
It's a glycogen synthase kinase three inhibitor, right?
Some of these are anti-cancer drugs.
Then you've got a Repsox TGF beta inhibitor, which is a direct cancer inhibiting drug.
And then you've got another drug called Tranelcypro...
(38:39):
tranylcypromine, T-R-A-N-Y-L-C-Y-P-R-O-M-I-N-E.
It's an MAO inhibitor, which is kind of like an antidepressant.
And then there's a supplement called forskelin, which is good at increasing cyclic AMP.
They combine it also with sodium butyrate and with alpha-ketoglutarate.
And fibreglass
(39:00):
Fibroblast growth factor is actually increased by a peptide called BPC157.
They were using fibroblast growth factor.
So they put together this cocktail and they gave it to mice and they reversed theirepigenetic age without having to do any genetic manipulation.
Right.
Yeah.
Isn't that amazing?
(39:21):
Now, the flip side of that coin is that
They could, mice are cancer prone, right?
They're cancer prone mammals.
When the mice were taking these, this cocktail, not only did they get younger, they couldnot give them cancer.
(39:41):
Yes, when they try to inject them with things that they know will give mice cancer, theywould laugh it off.
They would not get cancer.
That's...
Whoa.
That's a freaking game changer.
Tell me about it, right?
So I now have in my possession this cocktail and I'm gonna start taking it actually.
(40:04):
And I'm confessing that here on the podcast, but I've gone to some significant lengths tokind of pull all that together.
I'm really curious and I'll report back on the podcast actually.
I'm doing testing ahead of time so I can...
I'll share with the audience, you know, how this is working.
But I think the combination of this was some of the other things I'm doing.
(40:25):
The plasma freezes and I'm also reprogramming the stem cells in the third ventricle of thebrain and that are in the wall of the third ventricle of the brain.
I'm doing that on Monday and I'm going to, I've done testing today and I'm going to dothat on Monday in conjunction with plasma freezes and the analytics.
And then I'm going to follow it up with.
(40:47):
another test to see how that's doing.
And then I'm going to layer in the uh cocktail of molecules.
I'm going to see just how young can I get, right?
Because it's really the idea is, you know, how good can we be?
And uh when you look at my organ systems, they're really quite youthful.
I mean, when you look at all the markers and you look at, I mean, it's really, I was justgoing through it with the company today because they had a new testing reporting platform.
(41:16):
And their director of education research was basically saying, gosh, I wish I had yournumbers.
I wish I had your profile.
So it's pretty interesting.
But I think.
what is that cocktail again?
I just read it off to you.
Let me read it off again.
You won't be able to get a hold of it.
If you're listening to this, it's going to be difficult to pull this together.
(41:39):
It's valproic acid, CHIR 99021 uh Repsox, tranulocypramine, forescalin, sodium butyrate,alpha ketoglutarate.
Now those last ones you can get.
You can get forescalin online.
You can get sodium butyrate, can get alpha ketoglutarate.
have also been, interestingly enough, foreskin has been shown to improve testosterone,actually.
Sodium butyrate, of course, increases uh fiber in the gut.
(42:02):
And alpha-ketoglutarate has some longevity benefits on its own.
But the magic seems to happen when you combine these things together, as is most things inmedicine.
Right.
So you can read about one thing, but it's actually so important as you listen to this tounderstand it's not just about, he said alpha ketoglutarate.
I'm that's the one I can get.
(42:22):
I'm going to take that and by gosh, I'm doing everything I should.
mean, God bless the thought process, but you have to understand there are limitations tothat.
Right.
You may be getting 1 % of what you would get by doing the whole combination.
And this is why it's so important to think about not only the combinations, but thesequencing.
And that's why it's so important.
looping back to where we started to do the testing, right?
(42:45):
Where are you?
What do I need?
And how do I orchestrate myself to actually move back the pieces that are headed towardsthe cliff, right?
So that's really the key.
And that's what we, that's our philosophy here at Gladden Longevity.
It's how we go about everything.
So yeah.
So obviously as a doctor, medical doctor, and as a researcher, you're able to get some ofthose compounds that I couldn't get.
(43:16):
But what do you think the pricing for, I mean, if this works out for you, do you seeyourself bringing this to clients?
I'm always a pointy end of the stick, right?
So if I can if I can figure out that this is actually working and it's safe and I'm seeingsignificant changes that corroborate, you know, what other research has been saying, then
(43:38):
I will allow other clients once we've done proper testing and, you know, make sure thatit's the right thing for them and all that.
There's many things, you know, not hoops, but it's just we want to be safe, right?
It's safety first.
oh
And so if we feel like somebody is candidate, we would let them know that there's a waythat they could put this together.
Right.
(43:58):
So we don't have it inside of a trial currently.
And so I'm kind of going outside on we may bring it into a in a way to do that.
That might be a next step.
But we would we would diligently work to uh enable other people to have access to it.
Let's just say that.
So, yeah.
sign me up for that trial.
I'm, I, I, sounds like a freaking game changer.
(44:22):
Absolutely like a game changer.
And I'd get my ass down to Dallas and, be there and get some other stuff done while I'mthere.
Sure.
Yeah.
No, exactly.
It is a process, you know, like you do want to do the plus you do want to go through thesesteps because what it does is it makes everything else you do that much more effective and
(44:42):
that much better.
You need less of the other stuff when you do the right things to get ready for it.
It's kind of like, well, I've got I've got some some bare dirt out in the back of my yard.
I'm going to throw some grass seed out there.
It's like, OK, great.
Well.
You know, as opposed to I'm going to go out there and till the soil and put stuff in andmake the top.
So I want to get all this and do all that.
Then I'll put the seat on.
(45:03):
Then I'm going to cover it and I'm going to water it.
I'm going to do all these things.
You know, who's going to get the better yard?
Right.
It's just it's really the same thing.
Quite honestly, it's just you're dealing with biology.
It's the right sequence, the right preparation, the right understanding.
What's my soil need?
Why does it need more phosphate?
Does it need more?
you know, nitrogen, what, you know, what does it need?
Right.
(45:24):
And so you give it that in conjunction.
Now all of sudden you've got a bumper crop, right.
Either grass or whatever you want to grow.
And that's how, that's how we think here as well.
So we're just farmers in the end.
Right.
So, yeah.
Final topic, lifestyle science and hormesis, exercise, sauna, fasting.
Largest, safest effect sizes still come from smartly dosed lifestyle stressors.
(45:50):
Yep, I think this is you can never get away from this.
So we've talked about a bunch of pretty fancy stuff we really have.
It's pretty fancy and very cutting edge.
And yet some of these lifestyle things, exercise, saunas, cold plunges, sleeping well, youknow, you can never get away from that.
And, you know, I'm you know, we've been on for about an hour.
I will just say that, you know, you want to continue to do all the good things that you'redoing.
(46:15):
And if you're not involved with those yet, want to lean into those.
Make sure you're getting, know, cardio is really how you build VO2 max and VO2 max is howyou live a long time.
Muscle mass is important and you need to build it and you want strength and you want bonedensity.
From our perspective, we do that in about two days a week.
It's the cardio that we focus on and we end up with muscle mass.
(46:37):
That's great.
And, you know, because we're hormonally replete, so we build muscle.
quickly and but we also have really high VO2s and you know that's the combination thatwe're going for.
And then we use sauna, use ozone sauna, we use a cold plunge intermittently.
I don't have a cold plunge here in the office.
There's reasons for that.
A lot of them had to do with building codes and everything else when we were looking atputting in and it was going to be like a $50,000 proposition to put in a cold plunge.
(47:04):
I'm like, I don't think so.
So that being said, we love cold plunge and sauna, the data on sauna is incredible, right?
mean, 45 % reduction, all-cause mortality, 50 % reduction in heart disease, 65 % reductionin dementia and Alzheimer's.
So using the sauna five days a week, four days a week actually for 20 minutes at 175degrees or 180 degrees or the equivalent with an infrared sauna is, you know, it's money
(47:31):
in the bank.
All those lifestyle things that you're doing, you know, don't be dissuaded from that whenyou hear me talking about some of these special things.
That's still the blocking and tackling.
And then if you can lay some of these other pieces on top, now it gets super exciting.
Right.
So that's kind of kind of what we're talking about.
Yeah.
(47:52):
Well, Dr.
Gliden?
Yes, sir.
Let's finish off August strong.
And if any listeners want to send Dr.
Gladden a question, we love answering them here on these monthly calls, monthly calls.
All you need to do is just email us at podcast @ Gladden longevity.com.
That's podcast @ gladden longevity.com.
Welcome to the Gladden Longevity Podcast with Dr.
Jeffrey Gladden, where our passion is helping you become an age hacker.
On this show, we want to help you optimize your life energy, longevity, health, and humanperformance with impactful and actionable information by answering five questions.
How good can we be?
How do we make 100 the new 30?
(00:48):
How do we live well beyond 120?
How do we live young for a lifetime?
And how do we develop a 300 year old mind?
I'm Steve Reiter and
Dr.
Gladden, we're back for another monthly Q &A.
Yeah.
Excited to do it with you.
Good to see you, Steve.
Yeah.
see you too, my man.
(01:08):
So how's your August gone thus far?
it's been pretty amazing actually, lots of cool things.
And, we're actually in this podcast, we're going to talk about some of the stuff that I'vegot coming up.
So, even next week, so it'll, it's going to be a good August all the way through.
next week.
Well, the first topic we're going to talk about is proteomic organ age blood tests and thepace of aging markers.
(01:36):
I've never heard of an organ age test.
This is new to me.
right.
we're theoretically answering listeners questions, but I will tell the audience that Itook poetic license here and wanted to share with you things that I think you'll find
interesting to hear about.
And the first one is to understand that, of course, we're a mosaic of many ages.
(01:58):
You've heard us talk about that on the podcast before, and every organ really has its ownage, if you will.
Um, mm-hmm.
mean, I think about that when I think of someone who's drank their entire life.
Obviously their liver is going to be older, if you will, than the rest of their body.
And I'm sure other organs, but I didn't really realize that my kidneys could be older thanmy liver or my heart.
(02:25):
Absolutely.
Yeah.
No, every organ system is kind of a standalone, you know, down to bone, skin, muscle, andthen the internal organs, you know, all the internal organs, pancreas, liver, kidneys,
adrenal glands, stomach, GI tract, colon, heart, lung, and then brain, of course, and thenervous system in general, which is another really, really interesting area.
(02:50):
You know, one of the things that we've been doing is as we've been doing functionaltesting to look at those organ systems, like what is your VO2 max?
You know, what are your liver parameters based on blood testing?
What are your kidney parameters based on blood testing?
And we go about that with more comprehensive panels than most people certainly in generalmedicine would do.
And yet beyond that is another layer of
(03:12):
kind of peeling back the onion on what is the age of your organs.
And so with DNA methylation testing, TrueAge Diagnostics is the company that we've beenusing.
They will give you organ system ages for about 11 or 12 different organs, your brain, yourheart, your kidneys, your liver, your lungs, things like that.
And what they're doing is they're looking at DNA methylation patterns
(03:36):
that are reflective of those organs and then essentially estimating the age of that organ.
And then they give you a composite age of all of those organs, right?
So you get the composite age and then you get the breakdown per organ system, which isinteresting.
If you peel the onion back a little bit further, you can actually look at protein markersin the blood, which is referred to as proteomics.
(03:59):
em And
So now you've moved outside the nucleus of the cell where the DNA methylation patterns arebeing identified and now you're looking into the cytoplasm of the cells and in the blood
it's the plasma itself and you're looking for proteins and those proteins, theconfiguration of those proteins, the number of proteins that there are of particular types
(04:23):
will create a picture.
of what the underlying organ status is or age is in this case, right?
So, and what's happening is they're looking at these uh protein profiles compared to theselarge cohorts of people where they've collected this in the past.
(04:46):
for example, in the UK, there's a biobank that has about 45,000 individuals in there.
And so they can compare
your protein signature profile to 45,000 other people to give you an idea of kind of whereyou stand in the against the general population.
Right.
And it turns out that it can be helpful for identifying problems prior to them sort ofshowing up.
(05:12):
And there's there's a new test that we're excited to get our hands on.
It's not here yet.
I talked with the CEO of the company.
last week, actually, via email.
And he tells me that the lab, they're a company out of India called TZAR.
He tells me that the lab in the US is going to open up in Denver.
(05:34):
He said they were getting ready to sign some agreements and then they need to kind ofbuild it out.
So hopefully this fall.
Of course, I've been told it'll be in three months, about six times.
But that being said,
When that comes online, they have a test called an all-organ biopsy that's now looking ata combination of proteomics and transcriptomics, which are the messenger RNA signals that
(05:59):
come off of the DNA.
And combining those two things with some DNA profiling, et cetera, to give you what theycall an all-organ biopsy where you can go in and through that technology also get a status
update on each organ system.
And if you're really serious about longevity, then it's important to understand thatyou're really only as young as your oldest age, right?
(06:26):
So you really want to know what is the status of each organ.
It's kind of like, um, you know, building a company, you want to know the status of eachdepartment, how well is it performing?
Or if you've got a race car, for example, you want to know what each of the componentsstatus is because your car is only going to be as good.
durable and fast as the weakest component.
(06:48):
So same is true for us.
And so it's really exciting to me to see that testing is really rapidly moving in thisdirection.
Now, the omics testing right now, the proteomics I was talking about, there is a group outof Stanford apparently called Vero, V-E-R-O slash T-E-A-L, Vero Steel Omics that
(07:11):
has research partnerships.
And those tests are gonna be around $1,000 probably to get things done to look at your oldorgan age.
The all organ biopsy test is gonna be five or $6,000 to get that done from what Iunderstand.
So these tests are not necessarily inexpensive, but they are remarkably proficient atcharacterizing
(07:34):
not only a status, but in the case of T-SAR, actually telling you things you might beheaded towards, like are you headed towards dementia?
Are you headed towards a heart attack?
Are you headed towards a stroke?
Are you headed towards developing cancer for that matter?
And so getting that sort preemptive information becomes really very powerful.
So this is one of the reasons we're so interested in it.
(07:56):
And then of course there is...
Many people have heard about the pace of aging.
This was popularized by Brian Johnson with the Longevity Olympics, where he was using oneparticular parameter, the rate of aging, if you will, that came out of a town in New
Zealand called Dunedin, D-U-N-E-D-I-N, Dunedin.
(08:17):
And it was called the Dunedin Pace Trial.
They ran a trial over there in New Zealand to see how people were aging.
And from that, they...
looked at DNA methylation patterns and developed this clock, if you will.
So you can see in a chronological year how much you're aging.
Are you aging more than one year when you go through a chronological year or are you agingless than one year?
(08:38):
And so this is also nice to superimpose on top of these ohmic ages, if you will.
So the bottom line is that we're getting better at
and actually understanding where somebody is in the aging process, which of course is thefirst thing you've got to know if you're going to make the race car race longer or faster
(08:58):
or better, right?
And then there's a lot of things that can be done if you find that there are manylifestyle interventions or many supplements and things that you can modify depending on
the findings, but it's a really, really cool area.
Hmm.
know how that strikes you as every man on the call here, Steve, but it's prettyintriguing.
(09:23):
We're doing a lot of the testing.
I mean, we're all the testing now.
And in fact, some years ago, I developed a proteomic and transcriptomic test to look atthis very thing related to the hallmarks of aging.
It's just that at that point in time, it was prohibitively expensive to do it.
became almost like $14,000 or $15,000 to do a test.
And it was just like...
(09:43):
You know, nobody can really justify that.
So it's nice to see that things are progressing and getting cheaper.
Yeah.
So how much is that looking to be in terms of being tested now that things are gettingcheaper?
Yeah.
So it's going to be, know, you right now, if you want to do a true diagnostic test and youwant to do a combination of several of their tests, it's I don't have the exact numbers in
(10:12):
front of me, but you can probably get that done for, I'm going to say an interpreted andgone through and everything for around a thousand dollars.
Right.
So it's not.
Yeah, not.
drop from the 1415 that you had developed.
well, it's a little bit different.
It's a little bit of a tangential test to what I was developing.
The other tests that are being developed, though, seem to be sort of shaving some expenseoff of that.
(10:37):
But I was doing uh both proteomics and transcriptomics, which is looking at RNA andproteins both, right.
And the tests that we've been talking about are just proteomics only, right.
So they are going to be cheaper.
just by default, but even with that, they're getting cheaper.
Even the proteomics are getting cheaper, right?
So now we're down around maybe $1,000, $1,500, something like that.
(10:58):
yeah, mm-hmm.
Yeah, so it's good stuff.
So.
excites you about this and practically how do you see this helping people in their healthjourney?
Yep.
So practically there are two sides of the coin.
One is, I headed towards a cliff?
I don't know I'm headed towards.
This is a, this is, this is way to identify that and which organ system is involved inthat.
(11:22):
Is it your immune system?
Is it your cardiovascular system?
Is it your brain?
All those things can be answered.
And as a testing is refined, particularly with the T-SAR testing, we'll be able to see, it
Alzheimer's, is it Parkinson's?
Is it a stroke versus a heart attack?
You know, these kinds of things.
So there's even more precision in knowing what cliff you might be headed towards.
(11:45):
The second reason it's really important is if you're not headed towards a cliff, you maybe looking towards a cliff, right?
You're not running towards it, but you're kind of pointed in that direction.
That's helpful because if you can intervene sooner, you can steer yourself away from that.
even looking in that direction, let's say, right?
And if certainly if you're running towards it, there's a lot that can be done to slow thatdown or go the other way to where you're running away from it, right?
(12:09):
So that's the power of knowing.
There are lots of interventions we can do to do that.
Then the other thing is that for the people that are really looking to optimize theirlongevity through their lifestyle and supplements and sleep and the trackers, the
wearables and things and all the things that they're doing, the question,
becomes, well, jeez, I'm doing all this.
How well is it working out?
(12:30):
Right?
How good am I doing?
And am I putting the energy, time, attention, and resources into the things that matterthe most?
And so this gives you an idea to see what matters most and adjust your interventions tomake sure you're addressing the things that are most important as you keep the other
things going forward.
(12:51):
it's positive all the way around as I see it.
Yeah, yeah, sounds incredible.
So the next topic you wanted to talk about was senolytics and multi-drug gerotherapy.
Rapamycin and Tramatinib?
(13:12):
Well, it's the Satinib and Kursatin is one.
Those are two medications that people have heard about.
But let's talk about, and Fisetin is on there as a nice analytic, about 20 milligrams perkilogram per day.
So you can get your weight, take your weight divided by 2.2, that's your weight inkilograms and multiply by 20 milligrams.
(13:32):
And now you've got a dose of how much Fisetin you might want to take two days in a row.
and that you don't have to be taking it every day.
And you might want to repeat that every couple of months.
But what's helpful in pruning senescent cells is, again, with new testing that we have,there's a new test called Sapir P16 that looks at senescence in the immune system.
(13:57):
There's a UCLA test that looks at the anatomy of the immune system to give you an idea ofsenescence.
also from the true age DNA methylation, they will give you a snapshot of your immunesystem and how youthful or senescent it may be.
So we have ways, and then there's another test that can be done that looks atbeta-galactosidase, which is not the most perfect marker for senescence, but it does give
(14:20):
you kind of a ballpark feeling of what's going on.
And so that's interesting also.
So if you have an idea that your senescent cell burden is building up, as it does as weage, and of course these are the zombie cells that simply take up space and don't really
function, so it's like having a company with 100 employees and 20 of them show up to worksenescent, it means they're taking up space, but they don't do anything.
(14:42):
So the productivity of the company goes down, but then when they become secretory, nowthey're secreting these inflammatory cytokines into the environment, and now they start
recruiting other employees
to become senescent, so they stop working.
And then they're turning off the lights and the wifi and locking the doors and making itdifficult for the people or the cells or the individuals in this analogy who still are not
(15:07):
senescent, it makes it very difficult for them to work properly.
And so this is a big part of why aging is an exponential process, right?
Because it's a downward spiral and you can see that if you had a company and now you have20 and then you have 30,
and then 35 and then 38 and then 40 employees that are in this scenario and the lights areoff, you can see the company is just going to crater, right?
(15:30):
mean, the productivity is going to crater literally.
So that's what aging is.
And so being able to actually prune these senescent cells, fire these people from thecompany, right?
So that they leave is very important.
And in doing so, you're starting to turn down the inflammation.
that goes along with aging and the inflammation is driving more oxidative stress at thecellular level, which is also very damaging to the underlying, you know, functioning parts
(16:00):
of the, of the cell and other cells that are working properly.
So it's a real kind of a cleaning house kind of scenario.
Now, what we found is that, we really liked the P16 INK4A test that I mentioned was a
SAPIER bio, S-A-P-E-R-E, it's great and it can actually be treated by taking SGLT2s.
(16:23):
It's been shown to actually reverse that.
These are diabetes medicines that basically stop glucose from being reabsorbed through thetubules in the kidneys and you excrete the glucose into the urine.
which can lower blood sugar.
It's also been found, so it's used for diabetics, but then it was found that it's actuallygood for heart disease.
It's good for arterial disease.
(16:44):
And now it's being shown to actually be good at rebooting the immune system fromsenescence back to an active immune system, right?
Which is super important.
And the reason having an active immune system that's not senescent is so important.
is because it's your immune system that's out there.
The natural killer cells are actually pruning senescent cells for you.
(17:06):
So as you make the immune system more youthful, you now start to actually do for yourselfwhat previously you were asking the supplements to do.
And you're also scavenging for tumor cells when they show up and you're killing thosebefore they actually take hold and develop actual cancer, right?
So.
When you think about people that make it past 100, they really have three things incommon.
(17:30):
They have really robust immune systems.
They have very good cardiovascular systems, and they actually have very resilient brains,right?
And those seem to be, I mean, there are other things, of course, as well, but those threeseem to really be central.
So.
is kind of the drivers of having robust immune system, cardiovascular, healthy brain asyou age?
(17:59):
Is it genetic?
Is it lifestyle?
Is it a combination of those two?
Is it something else?
Well, there's always your genetic component to everything, but lifestyle plays a role.
You know, the more inflamed you are, the more infections that you face, the more timesyour immune cells have to divide.
And every time they divide, those telomeres inside the immune cells get shorter.
(18:23):
So the immune system is very susceptible to telomere shortening.
And I hadn't mentioned telomere shortening yet.
but I was about to when you asked the question, so I'll mention it now.
When telomeres get short, being able to re-lengthen telomeres, right, through things likeTA65 or Isogenics or TAM818 or now hyperbaric oxygen therapy if you want to wear a mask
(18:44):
for 90 minutes a day, five days a week has been shown.
Brian Johnson showed he reversed telomere lengths for himself.
There are other therapies out there now looking at gene therapies where they insert
the TERT gene into the cell using an adenovirus vector and they put it into the cell, notinto the nucleus, but into the cytoplasm of the cell so that now you're making more
(19:07):
telomerase, which is the enzyme that re-lengthens telomeres.
And that's interesting also.
So the point is that there are things to re-lengthen telomeres, but equally important isremoving things that are shortening telomeres.
You can't re-lengthen what you're actively shortening, right?
Um, so the first thing to do is to stop shortening the telomeres.
(19:28):
Well, how do you do that?
Well, one is you, you know, if you've got chronic allergies, if you've got chronicinfections, if you've got mold, if you've got Lyme, if you've got, you know, gut issues
that are, keep you chronically inflamed, your immune system is dialed up all the time.
It's working over time and those telomeres are shortening and it's getting weaker and ismuch more prone to become senescent earlier.
(19:50):
I don't know if that helps answer your question, but.
That's a big piece of it, the lifestyle piece and the chronic infections, things you'reexposed to, right?
So, yeah.
So the interesting thing about the senescent cells is when they occur and they start tosecrete these inflammatory cytokines, we can measure those.
(20:11):
We can measure IL-6 and TNF alpha, right?
And HSCRP, all of those are indicators.
And then there are other ways to help with this system.
So what we do is we will use a senolytic
system like say, Fisetin and we'll take it and then we'll do, in fact, I'm going to do aplasma foresis on Monday.
(20:35):
I'll probably take some Fisetin over the weekend for two days.
Prior to...
prior to this plasmapheresis because I'm gonna be basically killing off senescent cells.
I just got a test back from TrueAge in June and I don't have a lot of senescent cells andI did the Saphir P16 test and I have a very youthful immune system, like incredibly
(20:56):
youthful, right?
Like a lot of naivete in my immune system, not a lot of overcommitted cells.
my immune system is youthful in sense that it can adapt to new challenges, right?
So I'm gonna, through the testing, through the testing, yeah, you do the tests.
So anyway, I'm gonna take some Fisetin over the weekend and do Plasmapheresis.
(21:17):
Well, why would you do that?
Well, it's great because if you're gonna go in and kill these senescent cells, you'regonna basically dump a bunch of gunk into the system, right?
You do Plasmapheresis, you take all of that out.
Plasmapheresis is when you,
hook yourself up to the machine and you're pulling blood out of one arm.
You run it through a large centrifuge, which separates the cells, right?
(21:37):
The red cells and the white cells and the platelets, they sink to the bottom as thecentrifuge spins.
And then the plasma rises to the top.
Well, in the plasmas where all those inflammatory cytokines and proteins are.
So you throw that away and we can throw away three liters at a time, right?
And replace it with saline and albumin.
We can do that safely.
And so when you do that, it's almost like now you've killed off the bad guys and nowyou've cleaned out the system.
(22:03):
And then we all.
It is quite a bit.
It's almost like a full oil change, right?
Um, if you're going to donate plasma, you can only donate 200 CCs at a time, but you candonate two times a week, right?
So you replenish your plasma quickly.
but this seems.
Yeah.
is significantly more than.
(22:26):
That's right.
That's my point.
I'm putting it in perspective.
It's a lot more than 200 ml.
So it'd be five of those in a liter, right?
So this would be 15 times that.
Yeah, but it has the ability to actually really clean the system, right?
If you're going to clean the system, you clean the system and then the body rejuvenatesvery quickly, right?
And so anyway, this is a really, really powerful
(22:51):
scenario and when we're working with people that are, let's say they've sold a company andthey leverage their health to kind of get it across the finish line, right?
And they know it, they've been burning midnight oil and they're stressed and they haven'tbeen eating well, haven't been able to exercise and all that stuff.
Their body is full of these senescent cells.
And we can go in and through a series of these, right?
(23:12):
Like maybe doing this every month or six weeks.
for three, four, five, six sessions, you can actually really start to reboot somebody.
Whereas it would take them years to try to reboot what we can do in a matter of months uhusing something like this.
And then of course there's other interventions with lifestyle changes and teaching them tomanage stress and other things.
(23:33):
anyway, it's a great hack to be able to kind of go in and salvage somebody as well as forpeople that are doing well to intermittently.
you know, maybe every quarter or every four months or something like that, three times ayear doing this to kind of keep them to keep them young.
Right.
So, yeah.
(23:53):
So the idea then is to clear out the bad stuff and then rebuild.
That's it.
That's it.
You don't want to try to rebuild in the middle of a mess.
And this is also true if you're going to be doing regenerative therapies with stem cellsor exosomes or embryonic, you know, placental or cord blood factors or, whatever you have
(24:21):
access to PRP for that matter, platelet rich plasma, which is full of different signalingmolecules.
So
There are many regenerative tools out there, but those regenerative tools, my analogy forthat is that those are like Olympic swimmers, right?
And if you put those Olympic swimmers into a swimming pool that's full of, you know, lawnchairs and, and, and logs and sticks, branches from trees that are fallen in there,
(24:49):
they're not going to be able to do a very good job.
In fact, if you take stem cells and you put them into a Petri dish with
uh somebody, an older person's plasma, they die.
They don't do anything.
They die.
Okay.
And if you put them into the plasma of a young person, then they start to actually dotheir work.
(25:11):
Which isn't that interesting?
Yeah.
So you really want to, if you're listening to this, it's so important if you've got aproblem and you're thinking about
Oh, I want to fix my knee, my hip, or, you know, I'm thinking about getting a stem cellprocedure, even for your skin, for your face or whatever else.
you know, my doctor wants you to do exosomes.
(25:32):
Okay, that's great.
But if you haven't cleaned out the swimming pool, right, you're not going to get nearlythe results that you would if you sort of sequence it properly, where you actually prune
the senescent cells, take out the trash.
and then start to put in the rejuvenation factors and then support those rejuvenationfactors with other factors, right?
(25:53):
To write supplements for the indication, the right peptides for the indication, that kindof thing.
So, yeah.
Well, the next topic that you wanted to talk about big in the news right now, GLP ones,but this is GLP ones as Jero therapeutics beyond weight loss.
(26:14):
know about GLP ones for weight loss, but this was kind of interesting as something elseyou could use it for.
Yeah, so GLP-1s in my mind have really turned into a mixed bag.
They have really turned into a mixed bag.
So when GLP-1s are introduced, they were introduced basically to aid with diabetescontrol, right?
(26:38):
So a GLP-1 agonist would go in and when you take in sugar, and creatine comes in, GLP-1comes in, GLP-1 causes glucagon to go to work, but it also...
boost insulin release, right?
So that all of a sudden now you're managing the sugar that came in better than you wouldhave otherwise.
And so that was the theory behind them.
(26:58):
But then they discovered that the GLP-1s were actually having a beneficial effect on heartdisease, that people were less prone to heart attacks, that their arteries were doing
better, right?
And that their kidney function was improving.
because diabetics, you know, always have kidney compromised and they start to find thatthe protein that was leaking in the urine was going down and that the trajectory of kidney
(27:24):
loss was changed.
They were losing kidney function at a slower rate or they were maintaining kidney functionand not losing it at all.
And in some cases actually reversing kidney functioning, having kidney function improve.
And so...
Right.
So all of a sudden it's like, wow, these, these GLP ones are having a lot of let's call itoff target effects that are very useful.
(27:49):
And then it started to be shown that, you know, they, they could decrease appetite.
So then they were scooped up, as weight loss drugs.
Right.
And there are a number of them out there, ozempic,
And it's probably, you know, kind of the hallmark, GLP-1.
And then there are other combinations of GLP-1s and GIPs, are little different peptides.
(28:13):
These are peptide drugs, by the way.
Again, modulate the same system.
Moderna is one.
And the deal here is that they will decrease appetite and hunger.
and they'll decrease, they'll also slow gastric emptying.
The downside to these drugs when they're used for weight loss or when they're used at allis that you can develop pancreatitis.
(28:35):
You can develop gastric stasis, right?
Where the stomach doesn't empty.
And what we find, people come to us all the time that are taking GLP-1s, or we have peoplethat come in and they want to start a GLP-1.
So we'll start a low dose GLP-1 for them.
very cautiously and what we've seen as we've looked at mixed populations of people is thatpeople are losing weight, but they're losing muscle preferentially.
(29:03):
And the fat that they're not really losing much in the way of fat because when you'restarving, so to speak, not getting enough calories, fat is not enough to sustain you.
Fat is simply calories, but the body needs other things.
It needs minerals and it needs vitamins and things like that that are inside muscle cells.
So when you're fasting, like a three day fast, a five day fast, we had a guy come in herewas on a 14, no, an 18 day fast, water fast.
(29:31):
We measured his, right.
And he just did this on his own without asking us, but he came back and we measured him.
He'd lost a ton of muscle and not very much fat at all.
And bone density goes down for these people.
So we think that GLP-1s, while they are good at sort of modulating appetite, the weightloss is not really constructive weight loss.
(29:54):
It's really our idea of weight.
It has to do with actually body composition.
Like we don't care what people weigh.
What we care about is what their muscle mass is and what their body fat is.
And you can be you can be six foot and 200 pounds and have a, you know, percent body fatof eight and be an amazing shape.
(30:16):
Or you can be 200 with a percent body fat of, you know, 30, right.
And be in terrible shape.
So it's not about the weight.
It's really about what's the composition of the body.
So we see that the GLP-1s when they're used for weight loss, many times are used too longand too high dose and leading to what I would call unhealthy weight loss.
Right.
So it's a big problem.
(30:38):
There are better ways out there to lose weight.
There's a drug, not a drug.
There's a supplement called Mimeo, M-I-M-E-O, Mimeo, M-I-M-E-O, I-I-O, maybe that's it.
I was trying to think there was an I in there.
Yeah, Mimeo.
So M-I-M-I-O, which basically
(30:59):
Um, has several components in it.
It has a bit of niacin.
So if you take too much niacin, it'll give you diarrhea.
So just know that I've done it, uh, and it's happened.
Um, but if you take two or three, uh, you should be okay.
And, different people's GI tracts are more or less susceptible to it, but it also has OEAand PEA and OEA basically decreases appetite and PEA decreases inflammation in the brain.
(31:27):
And
That supplement works remarkably well.
You can actually dial in your appetite suppression based on how many capsules you take.
You take one, you're not gonna feel much.
You take two, you feel a little bit.
You take three, it's, yeah, I'm feeling not really that hungry.
You take four, it's like, I'm not really hungry at all.
So you can actually dial in appetite suppression that way as a way to kind of retrainyourself.
(31:49):
And the other thing that's super helpful is to do a five-day fast-mimicking diet, which isactually a kit that's been designed by Prolon.
And in that kit, you are fasting, quote unquote, for five days, but you're actually eatingat the same time, which sounds paradoxical.
How can I be eating and fasting simultaneously?
Well, what they've done is they've orchestrated these meals, quote unquote meals to besuch that you do a couple of things.
(32:16):
One, you get in nutrients that your body needs, so you're not having to pull from muscleto they're giving you a little bit of carbohydrate so that you don't have to pull from
muscle either.
So they've shown that with a five day fat-swinging diet, you're not actually losing muscleor bone density.
This has been studied.
So that's very interesting.
But what you are doing is you are pulling from fat cells.
(32:38):
You are also changing insulin resistance.
You're also resetting your gut biome.
You're also changing your taste buds.
You're shrinking your stomach.
So you're, decreasing your appetite.
And at the end, it can be a good way to jumpstart into
a body composition optimization program where now you're going to take Mimeo, you're goingto do a fast mimicking diet, initially, maybe once a month for three months or so until
(33:05):
your system gets regulated.
But we feel like that's a much healthier way.
That being said, there is a role for GLP-1s and there's microdosing of GLP-1s, which seemsto give a lot of the benefits in the longevity space, brain health and things like that.
without
all the appetite suppression and all the side effects, right?
So it's about a 10th of the dose of a normal GLP-1.
(33:26):
So to go full circle on the GLP-1s, I think they still have a role, certainly a role fordiabetics.
And I think they still have a role in longevity.
It's just that when they're used for weight loss, I think they're actually beingcounterproductive.
interesting, huh?
So the idea is micro dosing, GLP ones to get that heart, kidney, cardiovascular benefits.
(33:50):
That's right.
And they're also showing now that it helps in osteoarthritis.
There's some new studies related to that, cardiovascular disease, as I mentioned.
So it's pretty interesting.
Yeah.
So that's fascinating because with everything I've heard about women and even some mendeveloping osteoporosis, using it to lose weight, that a microdose can get the benefits of
(34:19):
the good stuff without getting hit with the bad.
That's right.
You know, there's, I forget who said this, but it was said a long time ago.
But, you know, everything is medicine or everything is poison.
It's just a question of the dose, right?
Yeah.
(34:40):
Interesting.
All right, gene therapy and partial epigenetic reprogramming, OSK.
Yeah, so this is pretty fascinating.
So as I mentioned earlier, we were talking about inserting TERT, the gene TERT into thecytoplasm of the cell.
Well, it turns out you can actually insert several different genes.
(35:02):
You can insert Clotho, a Clotho gene to increase Clotho production.
We can actually measure Clotho in clients.
There's a couple different ways to do that.
And then you can also insert uh Tert, you can insert folistatin, which actually keeps youfrom breaking down muscle, right, which is interesting.
And there's some other genes that are being used also to help optimize longevity and bodycomposition, if you will.
(35:30):
So that's one approach to, you know, genetic.
quote unquote reprogramming to optimize youthfulness as we age.
The Japanese scientist, Dr.
Yamanaka discovered that he could reprogram the epigenetic age of a cell by activatingfour different genes.
(35:51):
And if he activated those four genes inside of a cell and he left them activated,
long enough, the cell would return to a pluripotent stem cell.
This is when the Nobel Prize was awarded for this back in 2012-ish, I think it was.
And we all heard about the fact that, my gosh, you can make a stem cell out of a skincell.
Do remember that when that was on the news?
(36:12):
Yeah.
That's an induced pluripotent stem cell.
It's induced by activating the Yamanaka factors to create a pluripotent, which means itcan become anything, stem cell.
So the problem with the Yamanaka factor activation is that
When you're activated, you actually increase your risk of cancer because the cellsde-differentiate enough that they kind of lose track of what they are, right?
(36:35):
And so now not only can they become anything, but they can also become cancerous.
So they figured all this out in mice and then they took away one of the genes that was theprime culprit.
So now they're only using three of these in mice and they're actually pulsing them on andoff.
I won't go into the mechanism, but they actually make them sensitive to a typical to a uhto an antibiotic that will either turn them on or off and doxycycline, I believe.
(37:02):
And with that, they could sort of in the stepwise fashion make a cell more useful, right?
Make a mouse more useful, right?
But they still found if they went too far that the mice would develop cancer.
So that was interesting.
Then a paper published in July of 2023 out of David Sinclair's lab at Harvard, who is oneof the major longevity researchers, was really interesting because they hypothesized that
(37:32):
they could actually reprogram the epigenetics of a cell in the same way that the Yamanakafactors did.
And what they would do is they would use instead of
gene therapy, let's call it, or gene manipulation, they would just use a combination ofmedications and supplements.
(37:53):
So think of it as chemical reprogramming of a cell.
And what they ended up showing was that with a specific combination of valproic acid,which is used for seizure modulation, it's a histone deacetylase inhibitor.
And we haven't gotten into
that, that's another topic, but it has to, it's kind of connected to DNA methylation.
(38:16):
And then a molecule called CHIR99021.
It's a glycogen synthase kinase three inhibitor, right?
Some of these are anti-cancer drugs.
Then you've got a Repsox TGF beta inhibitor, which is a direct cancer inhibiting drug.
And then you've got another drug called Tranelcypro...
(38:39):
tranylcypromine, T-R-A-N-Y-L-C-Y-P-R-O-M-I-N-E.
It's an MAO inhibitor, which is kind of like an antidepressant.
And then there's a supplement called forskelin, which is good at increasing cyclic AMP.
They combine it also with sodium butyrate and with alpha-ketoglutarate.
And fibreglass
(39:00):
Fibroblast growth factor is actually increased by a peptide called BPC157.
They were using fibroblast growth factor.
So they put together this cocktail and they gave it to mice and they reversed theirepigenetic age without having to do any genetic manipulation.
Right.
Yeah.
Isn't that amazing?
(39:21):
Now, the flip side of that coin is that
They could, mice are cancer prone, right?
They're cancer prone mammals.
When the mice were taking these, this cocktail, not only did they get younger, they couldnot give them cancer.
(39:41):
Yes, when they try to inject them with things that they know will give mice cancer, theywould laugh it off.
They would not get cancer.
That's...
Whoa.
That's a freaking game changer.
Tell me about it, right?
So I now have in my possession this cocktail and I'm gonna start taking it actually.
(40:04):
And I'm confessing that here on the podcast, but I've gone to some significant lengths tokind of pull all that together.
I'm really curious and I'll report back on the podcast actually.
I'm doing testing ahead of time so I can...
I'll share with the audience, you know, how this is working.
But I think the combination of this was some of the other things I'm doing.
(40:25):
The plasma freezes and I'm also reprogramming the stem cells in the third ventricle of thebrain and that are in the wall of the third ventricle of the brain.
I'm doing that on Monday and I'm going to, I've done testing today and I'm going to dothat on Monday in conjunction with plasma freezes and the analytics.
And then I'm going to follow it up with.
(40:47):
another test to see how that's doing.
And then I'm going to layer in the uh cocktail of molecules.
I'm going to see just how young can I get, right?
Because it's really the idea is, you know, how good can we be?
And uh when you look at my organ systems, they're really quite youthful.
I mean, when you look at all the markers and you look at, I mean, it's really, I was justgoing through it with the company today because they had a new testing reporting platform.
(41:16):
And their director of education research was basically saying, gosh, I wish I had yournumbers.
I wish I had your profile.
So it's pretty interesting.
But I think.
what is that cocktail again?
I just read it off to you.
Let me read it off again.
You won't be able to get a hold of it.
If you're listening to this, it's going to be difficult to pull this together.
(41:39):
It's valproic acid, CHIR 99021 uh Repsox, tranulocypramine, forescalin, sodium butyrate,alpha ketoglutarate.
Now those last ones you can get.
You can get forescalin online.
You can get sodium butyrate, can get alpha ketoglutarate.
have also been, interestingly enough, foreskin has been shown to improve testosterone,actually.
Sodium butyrate, of course, increases uh fiber in the gut.
(42:02):
And alpha-ketoglutarate has some longevity benefits on its own.
But the magic seems to happen when you combine these things together, as is most things inmedicine.
Right.
So you can read about one thing, but it's actually so important as you listen to this tounderstand it's not just about, he said alpha ketoglutarate.
I'm that's the one I can get.
(42:22):
I'm going to take that and by gosh, I'm doing everything I should.
mean, God bless the thought process, but you have to understand there are limitations tothat.
Right.
You may be getting 1 % of what you would get by doing the whole combination.
And this is why it's so important to think about not only the combinations, but thesequencing.
And that's why it's so important.
looping back to where we started to do the testing, right?
(42:45):
Where are you?
What do I need?
And how do I orchestrate myself to actually move back the pieces that are headed towardsthe cliff, right?
So that's really the key.
And that's what we, that's our philosophy here at Gladden Longevity.
It's how we go about everything.
So yeah.
So obviously as a doctor, medical doctor, and as a researcher, you're able to get some ofthose compounds that I couldn't get.
(43:16):
But what do you think the pricing for, I mean, if this works out for you, do you seeyourself bringing this to clients?
I'm always a pointy end of the stick, right?
So if I can if I can figure out that this is actually working and it's safe and I'm seeingsignificant changes that corroborate, you know, what other research has been saying, then
(43:38):
I will allow other clients once we've done proper testing and, you know, make sure thatit's the right thing for them and all that.
There's many things, you know, not hoops, but it's just we want to be safe, right?
It's safety first.
oh
And so if we feel like somebody is candidate, we would let them know that there's a waythat they could put this together.
Right.
(43:58):
So we don't have it inside of a trial currently.
And so I'm kind of going outside on we may bring it into a in a way to do that.
That might be a next step.
But we would we would diligently work to uh enable other people to have access to it.
Let's just say that.
So, yeah.
sign me up for that trial.
I'm, I, I, sounds like a freaking game changer.
(44:22):
Absolutely like a game changer.
And I'd get my ass down to Dallas and, be there and get some other stuff done while I'mthere.
Sure.
Yeah.
No, exactly.
It is a process, you know, like you do want to do the plus you do want to go through thesesteps because what it does is it makes everything else you do that much more effective and
(44:42):
that much better.
You need less of the other stuff when you do the right things to get ready for it.
It's kind of like, well, I've got I've got some some bare dirt out in the back of my yard.
I'm going to throw some grass seed out there.
It's like, OK, great.
Well.
You know, as opposed to I'm going to go out there and till the soil and put stuff in andmake the top.
So I want to get all this and do all that.
Then I'll put the seat on.
(45:03):
Then I'm going to cover it and I'm going to water it.
I'm going to do all these things.
You know, who's going to get the better yard?
Right.
It's just it's really the same thing.
Quite honestly, it's just you're dealing with biology.
It's the right sequence, the right preparation, the right understanding.
What's my soil need?
Why does it need more phosphate?
Does it need more?
you know, nitrogen, what, you know, what does it need?
Right.
(45:24):
And so you give it that in conjunction.
Now all of sudden you've got a bumper crop, right.
Either grass or whatever you want to grow.
And that's how, that's how we think here as well.
So we're just farmers in the end.
Right.
So, yeah.
Final topic, lifestyle science and hormesis, exercise, sauna, fasting.
Largest, safest effect sizes still come from smartly dosed lifestyle stressors.
(45:50):
Yep, I think this is you can never get away from this.
So we've talked about a bunch of pretty fancy stuff we really have.
It's pretty fancy and very cutting edge.
And yet some of these lifestyle things, exercise, saunas, cold plunges, sleeping well, youknow, you can never get away from that.
And, you know, I'm you know, we've been on for about an hour.
I will just say that, you know, you want to continue to do all the good things that you'redoing.
(46:15):
And if you're not involved with those yet, want to lean into those.
Make sure you're getting, know, cardio is really how you build VO2 max and VO2 max is howyou live a long time.
Muscle mass is important and you need to build it and you want strength and you want bonedensity.
From our perspective, we do that in about two days a week.
It's the cardio that we focus on and we end up with muscle mass.
(46:37):
That's great.
And, you know, because we're hormonally replete, so we build muscle.
quickly and but we also have really high VO2s and you know that's the combination thatwe're going for.
And then we use sauna, use ozone sauna, we use a cold plunge intermittently.
I don't have a cold plunge here in the office.
There's reasons for that.
A lot of them had to do with building codes and everything else when we were looking atputting in and it was going to be like a $50,000 proposition to put in a cold plunge.
(47:04):
I'm like, I don't think so.
So that being said, we love cold plunge and sauna, the data on sauna is incredible, right?
mean, 45 % reduction, all-cause mortality, 50 % reduction in heart disease, 65 % reductionin dementia and Alzheimer's.
So using the sauna five days a week, four days a week actually for 20 minutes at 175degrees or 180 degrees or the equivalent with an infrared sauna is, you know, it's money
(47:31):
in the bank.
All those lifestyle things that you're doing, you know, don't be dissuaded from that whenyou hear me talking about some of these special things.
That's still the blocking and tackling.
And then if you can lay some of these other pieces on top, now it gets super exciting.
Right.
So that's kind of kind of what we're talking about.
Yeah.
(47:52):
Well, Dr.
Gliden?
Yes, sir.
Let's finish off August strong.
And if any listeners want to send Dr.
Gladden a question, we love answering them here on these monthly calls, monthly calls.
All you need to do is just email us at podcast @ Gladden longevity.com.
That's podcast @ gladden longevity.com.
Popular Podcasts
24/7 News: The Latest
The latest news in 4 minutes updated every hour, every day.
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
The Clay Travis and Buck Sexton Show
The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.